Does hypolipidemic therapy prevent coronary heart disease?
Rifkind, B.M.; Levy, R.I.
Cardiovascular Clinics 6(2): 1-8
1974
ISSN/ISBN: 0069-0384 PMID: 4374303 Document Number: 81579
Document emailed within 1 workday
Related Documents
2001: Summaries for patients. Eating fruits and vegetables helps prevent coronary heart disease Annals of Internal Medicine 134(12): S-14Hamilton, V.H.; Racicot, F.E.; Zowall, H.; Coupal, L.; Grover, S.A. 1995: The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C JAMA 273(13): 1032-1038
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Niederberger, M. 1976: Therapy of coronary heart disease Wiener Medizinische Wochenschrift 126(32-35): 469-473
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Loeliger, E.A. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(19): 810-813
Mehta, J.L. 1982: Platelets and coronary heart disease: therapy update Geriatrics 37(5): 129-34 139
Zhu, G. 1996: Problems in interventional therapy of coronary heart disease Zhonghua Nei Ke Za Zhi 35(3): 147-148
Amano, K. 2003: Coronary heart disease and hormone replacement therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 5): 914-919
Meyer, J. 1983: Use of calcium antagonists in the therapy of coronary heart disease Der Internist 24(7): 408-414
Leschke, M.; Motz, W.; Strauer, B.E. 1986: Hemorheologic therapy applications in coronary heart disease Wiener Medizinische Wochenschrift 136(Special Issue): 17-24
Visser, J. 1970: The dilemma of anticoagulant therapy in coronary heart disease Nederlands Tijdschrift Voor Geneeskunde 114(29): 1221-1223
Erbel, R.; Ge, J.; Haude, M.; Görge, G. 1995: Alternative methods in interventional therapy of coronary heart disease Zeitschrift für Kardiologie 84(Suppl 2): 53-64
Bleifeld, W.; Spokojny, A. 1983: Therapy of coronary heart disease with calcium antagonists in clinical practice Die Medizinische Welt 34(47): 1335-1339
Egger, M.; Junghans, C.; Friis Moller, N.; Lundgren, J.D. 2001: Highly active antiretroviral therapy and coronary heart disease: the need for perspective AIDS 15(Suppl 5): S193-S201
Stauch, M.; Schmidt, A.; Kress, P. 1987: Problems in long-term therapy of coronary heart disease: clinical aspects Medizinische Klinik 1: 24-28
Saal, S.D.; Gordon, B.R.; Parker, T.S.; Levine, D.M.; Tyberg, T.I.; Rubin, A.L. 1989: Extracorporeal LDL cholesterol removal: role of LDL-pheresis in combination with other hypolipidemic therapy to regress vascular disease American Journal of Medicine 87(5n): 68n-74n
Böhm, C.; Christl, H.L.; Wald, G. 1982: Drug therapy of coronary heart disease. Comparative effects of nifedipine and isosorbide dinitrate Die Medizinische Welt 33(36): 1242-1244
Zhu, W.-x.; Chen, B.-s. 2005: The study progression of recombinant apolipoprotein A-IMilano in cardiovascular protection and therapy of coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 33(7): 673-675